In these circumstances, suitable medicines are immediately needed that can also help in vaccine production. In this chapter, a novel AI based architecture has been proposed to obtain influencial drugs for the COVID-19 treatment. Here, The COVID-19 (MT050943 and MT012098) data are taken ...
Although chloroquine and hydroxychloroquine possess antiviral and immunomodulatory effects, in practice benefit of their use for COVID treatment is controversial. Several studies investigating hydroxychloroquine were stopped and the French national medicines regulator suspended its use in clinical trials because ...
have emerged as the next modality in antivirals, ideal for providing antiviral medicines quickly in response to new viral outbreaks. The oligo HBV antivirals being developed work through RNAi to disrupt the disease mechanism. The viral hijack of the molecular machinery of the cell could b...
The antiviral Lagevrio (molnupiravir) is safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate COVID-19 who are at increased risk of developing severe disease, the Medicines and Healthcare products Regulatory Agency (MHRA) announced today. This f...
promotes prevention of COVID-19 through lifestyle modification as well as dietary management and prophylactic interventions for improving the immunity [31]. All these have led to a revival of interest in herbal medicines, novel nutraceuticals and herbal formulations with antiviral potency based on any...
ABSTRACT:On 4th November 2021, the first oral antiviral drug for COVID-19, molnupiravir (Lagevrio®), received full regulatory approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) in the UK. Molnupiravir is an orally bioavailabl
In January, the Medicines Patent Pool announced a similar deal with Merck, when it signed deals with more than two dozen companies licensed to make their COVID pill, molnupiravir. None of the companies that make COVID-19 vaccines have so far agreed to work with the group to allow other...
an FDA-approved molecule on the WHO Model List of Essential Medicines, showed an antiviral EC50of 310 nM. This molecule has anti-mycobacterial and anti-inflammatory activity39, and is used for the treatment of leprosy. Further studies are required to understand the mechanism by which this drug ...
During the coronavirus disease 2019 (COVID-19) pandemic, a wave of rapid and collaborative drug discovery efforts took place in academia and industry, culminating in several therapeutics being discovered, approved and deployed in a 2-year time frame. Thi
Australia is experiencing a fresh wave of COVID, seeing increasing cases, more hospitalizations and a greater number of prescriptions for COVID antivirals dispensed over recent months. In the early days of the pandemic, the only medicines available were those that treated the symptoms of the virus...